Age-related macular degeneration 2

Common Name(s)

Age-related macular degeneration 2

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Age-related macular degeneration 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Age-related macular degeneration 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Age-related macular degeneration 2" returned 31 free, full-text research articles on human participants. First 3 results:

Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration.
 

Author(s): Manabu Hirasawa, Keiyo Takubo, Hideto Osada, Seiji Miyake, Eriko Toda, Motoyoshi Endo, Kazuo Umezawa, Kazuo Tsubota, Yuichi Oike, Yoko Ozawa

Journal: J. Biol. Chem.. 2016 Apr;291(14):7373-85.

 

Choroidal neovascularization (CNV) is a pathogenic process of age-related macular degeneration, a vision-threatening disease. The retinal pigment epithelium and macrophages both influence CNV development. However, the underlying mechanisms remain obscure. Here, we focus on Angptl2 ...

Last Updated: 2 Apr 2016

Go To URL
Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study - Report 2.
 

Author(s): Maria da Luz Cachulo, Inês Laíns, Conceição Lobo, João Figueira, Luísa Ribeiro, João P Marques, José Costa, António Vieira, João Rodrigues, Dalila Alves, Sandrina Nunes, Miguel Costa, Victor Rodrigues, José Cunha-Vaz, Cecile Delcourt, Rufino Silva

Journal: Acta Ophthalmol. 2016 Sep;94(6):e442-53.

 

To determine the age- and sex-specific prevalence of early and late age-related macular degeneration (AMD) in two Portuguese population-based samples and to identify its risk factors.

Last Updated: 30 Aug 2016

Go To URL
Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
 

Author(s): Juan Wu, Eunyoung Cho, Walter C Willett, Srinivas M Sastry, Debra A Schaumberg

Journal: JAMA Ophthalmol. 2015 Dec;133(12):1415-24.

 

Despite strong biological plausibility, evidence from epidemiologic studies and clinical trials on the relations between intakes of lutein and zeaxanthin and age-related macular degeneration (AMD) has been inconsistent. The roles of other carotenoids are less thoroughly investigated.

Last Updated: 15 Dec 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Age-related macular degeneration 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov